Literature DB >> 10676844

Activation of STAT5 during EPO-directed suppression of apoptosis.

T Bittorf1, J Seiler, B Lüdtke, T Büchse, R Jaster, J Brock.   

Abstract

The ligand-dependent activation of the JAK/STAT (Januskinase/Signal Transducer and Activator of Transcription) pathway has been implicated in the explanation of cytokine-specific regulation of gene expression. Previous studies have reported conflicting results on the role of the transcription factor STAT5 in erythropoietin (EPO)-induced cellular responses. In this study we focused on the functional importance of STAT5 docking sites in the intracellular EPO receptor (EPOR) domain for the mediation of antiapoptotic activities. We demonstrate that EPO-dependent survival of erythroleukemic cell lines is accompanied by sustained STAT5 DNA-binding activity. The role of single tyrosine residues was dissected by the analysis of myeloid FDCP-1 cells stably expressing mutant EPOR proteins. The data show that receptors having a high potential to mediate antiapoptotic signals also effectively activate STAT5, whereas receptors lacking STAT5 docking sites are diminished in both activities. We conclude that the transcription factor STAT5 is functionally implicated in the EPO-dependent survival of cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676844     DOI: 10.1016/s0898-6568(99)00063-7

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.

Authors:  Alfredo Gorio; Necati Gokmen; Serhat Erbayraktar; Osman Yilmaz; Laura Madaschi; Cinzia Cichetti; Anna Maria Di Giulio; Enver Vardar; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

2.  EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.

Authors:  Jing Fang; Madhu Menon; William Kapelle; Olga Bogacheva; Oleg Bogachev; Estelle Houde; Sarah Browne; Pradeep Sathyanarayana; Don M Wojchowski
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

3.  Erythropoietin protects against diabetes through direct effects on pancreatic beta cells.

Authors:  Diana Choi; Stephanie A Schroer; Shun Yan Lu; Linyuan Wang; Xiaohong Wu; Yunfeng Liu; Yi Zhang; Herbert Y Gaisano; Kay-Uwe Wagner; Hong Wu; Ravi Retnakaran; Minna Woo
Journal:  J Exp Med       Date:  2010-12-13       Impact factor: 14.307

4.  AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia.

Authors:  Han-Tan Chai; Hon-Kan Yip; Cheuk-Kwan Sun; Shu-Yuan Hsu; Steve Leu
Journal:  J Inflamm (Lond)       Date:  2016-06-04       Impact factor: 4.981

Review 5.  STAT5 as a Key Protein of Erythropoietin Signalization.

Authors:  Zuzana Tóthová; Jana Tomc; Nataša Debeljak; Peter Solár
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy.

Authors:  Bao-Xin Ma; Jie Li; Hua Li; Sui-Sheng Wu
Journal:  Curr Ther Res Clin Exp       Date:  2015-08-04

7.  Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.

Authors:  Manfred Nairz; David Haschka; Stefanie Dichtl; Thomas Sonnweber; Andrea Schroll; Malte Aßhoff; John E Mindur; Patrizia L Moser; Dominik Wolf; Filip K Swirski; Igor Theurl; Anthony Cerami; Michael Brines; Günter Weiss
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.